PATENT CLAIM ANALYSIS

Application Number: 16399262
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "139100"]

Abstract:
The instant disclosure provides antibodies that specifically bind to human PD-1 and antagonize PD-1 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Claim (Index 20):
The isolated antibody of  claim 16 , wherein the amino acid sequence of the light chain consists of the amino acid sequence of SEQ ID NO: 19.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.34211
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15254315', '16165833', '15166305', '15606148', '15148720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7234501014104996
- 35 USC 102 Novelty (BERT): 0.5985415032998517
- Combined Prediction Score: 0.7109592415994348
- Mean Citation Score: 450.955682
- Max Citation Score: 497.47818
- Similarity Product: 472.2030437195492

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test